NSEGeneral Updates5d ago · 4 Nov 2026, 12:27 pm
General Updates
Natural Capsules Limited · NATCAPSUQ
✦ AI SummaryFundraise
Natural Capsules Limited has provided clarification on the object of the issue given on the corrigendum notice, regarding the utilization of proceeds from the preferential issue of equity shares and convertible warrants.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natural Capsules Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
NCL1993_04112026122630_Reg_30_PA.pdf
View document text
A C C R E D I T E D
ISO/IEC 17021
CERTIFICATION BODY
Date: November 04, 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, PJ Towers Exchange Plaza, C-1, Block G
Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai – 400001 Mumbai – 400051
Scrip Code: 524654 Symbol: NATCAPSUQ
Sub: Clarification under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 – Clarification on Object of the Issue given on the Corrigendum Notice.
This is with reference to the queries/clarification sought by BSE Limited and National Stock Exchange of
India Limited regarding Point F of the Explanatory Statement 1 & 2 in relation to the Object of the
Preferential Issue.
To remove any ambiguity/confusion mentioned in the bifurcation and note to the Object of the Issue,
the Company hereby provides a simplified clarification regarding the intended utilization of proceeds from
the Preferential Issue of Equity Shares and Convertible Warrants:
Clarification on Explanatory Statement to Item No 1
Point F:
The Objects of the issue through preferential offer:
The Company intends to utilize the proceeds raised through the Preferential Issue (“Issue Proceeds”)
of ₹ 2,00,25,000 towards the Working Capital Requirements and Capital Expansion, including
acquisition/establishment of new unit. The Company proposes to utilise the funds to meet its working
capital requirements arising in the ordinary course of business. This includes expenses towards
employee salaries, operational costs, and procurement of raw materials, vendor and service provider
payments. The funds will also be used for marketing, logistics, rent, insurance, statutory and
compliance costs, as well as advances and deposits required for smooth business operations. (“Working
Capital Requirements”), and for exploring new business avenues for Capital Expansion.
The Company intends to utilize the proceeds raised through the Preferential Issue towards Working Capital
Requirements and Capital Expansion
A. Working Capital Requirements:
The Company proposes to utilize the funds to meet its working capital requirements arising in the ordinary
course of business. This includes expenses towards procurement of raw materials, vendor payments,
operational costs, employee salaries, marketing, logistics, rent, insurance, statutory and compliance costs,
as well as advances and deposits required for smooth business operations.
B. Capital Expansion:
The proceeds will be allocated towards Capital Expansion to support long-term strategic growth. This
includes:
1. Capacity Addition & Modernization: Enhancing existing manufacturing capabilities, upgrading
plant machinery, and investing in process automation and technology to meet growing demand.
2. Strategic Growth & Business Avenues: Exploring potential expansion opportunities, including the
preliminary evaluation of acquiring or establishing additional new unit to expand operational scale.
A C C R E D I T E D
ISO/IEC 17021
CERTIFICATION BODY
Clarification to Explanatory Statement to Item No 2
Point F:
The Objects of the issue through preferential offer:
The Company intends to utilize the proceeds raised through the Preferential Issue (“Issue Proceeds”)
of ₹ 8,01,00,000 towards the Working Capital Requirements and Capital Expansion, including
acquisition/establishment of new unit. The Company proposes to utilise the funds to meet its working
capital requirements arising in the ordinary course of business. This includes expenses towards
employee salaries, operational costs, and procurement of raw materials, vendor and service provider
payments. The funds will also be used for marketing, logistics, rent, insurance, statutory and
compliance costs, as well as advances and deposits required for smooth business operations. (“Working
Capital Requirements”), and for exploring new business avenues for Capital Expansion.
The Company intends to utilize the proceeds raised through the Preferential Issue towards Working Capital
Requirements and Capital Expansion
A. Working Capital Requirements:
The Company proposes to utilize the funds to meet its working capital requirements arising in the ordinary
course of business. This includes expenses towards procurement of raw materials, vendor payments,
operational costs, employee salaries, marketing, logistics, rent, insurance, statutory and compliance costs,
as well as advances and deposits required for smooth business operations.
B. Capital Expansion:
The proceeds will be allocated towards Capital Expansion to support long-term strategic growth. This
includes:
1. Capacity Addition & Modernization: Enhancing existing manufacturing capabilities, upgrading
plant machinery, and investing in process automation and technology to meet growing demand.
2. Strategic Growth & Business Avenues: Exploring potential expansion opportunities, including the
preliminary evaluation of acquiring or establishing additional new unit to expand operational scale.
Yours Faithfully,
For Natural Capsules Limited
Akshay Dutta
Company Secretary and Compliance Officer
M.No. A80481